Letosteine

Letosteine
Clinical data
Trade names	Viscotiol
Routes of; administration	Oral (gastroresistant capsules)
ATC code	R05CB09 (WHO)
Identifiers
	IUPAC name 2-[2-(2-ethoxy-2-oxoethyl)sulfanylethyl]-1,3-thiazolidine-4-carboxylic acid;
Synonyms	2-[2-(ethoxycarbonylmethylsulfanyl)ethyl]-1,3-thiazolidine-4-carboxylic acid
CAS Number	53943-88-7
PubChem (CID)	68707
DrugBank	DB08939
ChemSpider	61958
UNII	6MVF9U95DW
KEGG	D07380
ChEBI	CHEBI:88271
ECHA InfoCard	100.053.509
Chemical and physical data
Formula	C10H17NO4S2
Molar mass	279.378 g/mol
3D model (Jmol)	Interactive image
	SMILES O=C(O)C1NC(SC1)CCSCC(=O)OCC ;
	InChI InChI=1S/C10H17NO4S2/c1-2-15-9(12)6-16-4-3-8-11-7(5-17-8)10(13)14/h7-8,11H,2-6H2,1H3,(H,13,14) ; Key:IKOCLISPVJZJEA-UHFFFAOYSA-N ;
(what is this?) (verify)

Letosteine is a mucolytic patented (U.S. patent 6987120) by Piero del Soldato of Milan, Italy.^[1] He filed his application in 2000.

References[edit]

This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.

Clinical data

Trade names	Viscotiol
Routes of administration	Oral (gastroresistant capsules)
ATC code	R05CB09 (WHO)
Identifiers
IUPAC name 2-[2-(2-ethoxy-2-oxoethyl)sulfanylethyl]-1,3-thiazolidine-4-carboxylic acid
Synonyms	2-[2-(ethoxycarbonylmethylsulfanyl)ethyl]-1,3-thiazolidine-4-carboxylic acid
CAS Number	53943-88-7^Y
PubChem (CID)	68707
DrugBank	DB08939^N
ChemSpider	61958^Y
UNII	6MVF9U95DW^Y
KEGG	D07380^Y
ChEBI	CHEBI:88271^N
ECHA InfoCard	100.053.509
Chemical and physical data
Formula	C₁₀H₁₇NO₄S₂
Molar mass	279.378 g/mol
3D model (Jmol)	Interactive image
SMILES O=C(O)C1NC(SC1)CCSCC(=O)OCC
InChI InChI=1S/C10H17NO4S2/c1-2-15-9(12)6-16-4-3-8-11-7(5-17-8)10(13)14/h7-8,11H,2-6H2,1H3,(H,13,14)^Y Key:IKOCLISPVJZJEA-UHFFFAOYSA-N^Y
^NY (what is this?) (verify)